NCT07252726 2026-02-09
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Phase 4 Recruiting
Ottawa Hospital Research Institute
Guerbet
Peter MacCallum Cancer Centre, Australia
Novartis
Novartis
Novartis